insights_auto
Sebab WUXI06 menurun 3.42%?
Terokai Dengan Lebih Terperincichevron_right
WUXI06:BKK
Wuxi Biologics (Cayman) Inc. KKPS DR
THB 5.65
arrow_downward
-3.42%(-0.20) 1H
12 Okt, 4:40:00 PTG GMT+7 · THB
search
Semua simbol
| Simbol | Harga | Perubahan | % Perubahan |
|---|
insights_autoMenjana cerapan popular untuk WUXI06...
Buka
THB 5.70
Tinggi
THB 5.75
Rendah
THB 5.65
Permodalan Pasaran
208.31B
Purata volum
104.18K
Volum
0.00
tgi 52 mgu
THB 6.25
rdh 52 mgu
THB 3.02
Syer tertunggak
4.12B
Bilangan pekerja
15K
Buka
THB 5.70
Tinggi
THB 5.75
Rendah
THB 5.65
Permodalan Pasaran
208.31B
Purata volum
104.18K
Volum
0.00
tgi 52 mgu
THB 6.25
rdh 52 mgu
THB 3.02
Syer tertunggak
4.12B
Bilangan pekerja
15K
Cerita berita
Daripada sumber web dan rakan kongsi berita
Invezz
·
19 jam lalu
3 pemangkin utama untuk Indeks S&P 500 minggu ini: bon, musim laporan pendapatan, CPI
Invezz
·
17 jam lalu
Dow Jones dibuka 190 mata lebih tinggi, pelabur memerhati pendapatan bank dan inflasi
Invezz
·
11 jam lalu
Dow naik 198 mata, saham AS bercampur menjelang keputusan pendapatan
The Motley Fool
·
13 minit lalu
If You Invest $5,000 in VOO Today, Here's What History Says It Could Be Worth in 20 Years
Profil
WuXi Biologics is a global Contract Research Development and Manufacturing Organization that provides open-access, integrated technology platforms for biologics drug development.
WuXi Biologics' roots date back to 2010, when it was founded as a division of WuXi AppTec and began building out capabilities and facilities required for biologics discovery, development and good manufacturing practices. After being spun off from its parent, WuXi Biologics went public on the Hong Kong Stock Exchange in June 2017.
As of 2021, WuXi Biologics has 18 manufacturing sites including ten in China, three in the United States, two in Ireland, two in Germany, and one in Singapore.
In August 2020, WuXi Biologics was selected to become a component of the Hang Seng Index in Hong Kong.
In January 2024, WuXi Biologics' share price fell on news that the United States Congress had introduced legislation to block any federal government contracts with the company due to national security concerns. The concerns stem from allegations, denied by the company, that it has worked closely with the People's Liberation Army as a part of the Chinese Communist Party's military-civil fusion strategy. Wikipedia
Perihal Wuxi Biologics (Cayman) Inc. KKPS DR